Target intelligence / Profile preview

Paracrine Immunomodulation

Molecular classification
Biological Process, Cell Signaling Mechanism
01

Overview

Paracrine immunomodulation is a physiological process in which a cell secretes biochemical mediators, such as cytokines, chemokines, or extracellular vesicles, to influence the activity and phenotype of nearby immune cells within the local microenvironment (Nature Reviews Immunology, 2018). Unlike endocrine signaling, which occurs over long distances via the circulatory system, paracrine signaling is localized, allowing for precise control of regional immune responses and tissue homeostasis. In oncology, cancer cells often exploit paracrine immunomodulation by secreting immunosuppressive factors like TGF-beta or IL-10 to create a 'cold' tumor microenvironment that evades T-cell mediated destruction (Frontiers in Immunology, 2020). Conversely, regenerative medicine utilizes the paracrine effects of Mesenchymal Stem Cells (MSCs) to dampen pathological inflammation and promote tissue repair without the need for direct cell-to-cell contact (Stem Cell Research & Therapy, 2021). Because this term describes a broad biological mechanism involving various signaling molecules rather than a specific protein or receptor, it is classified as a physiological process rather than a discrete therapeutic target.

Other names
Paracrine immune signalingLocal immunomodulationBystander immunomodulationParacrine immune regulation
02

Mechanism of action

Not applicable as a single molecular target; however, therapeutic strategies involve the use of secretomes or engineered cells to modulate local immune environments through the secretion of cytokines and growth factors.

03

Biological functions

Immune responseSignal transductionCell-to-cell communicationInflammation regulationTissue homeostasis
04

Disease associations

CancerAutoimmune diseaseChronic inflammationGraft-versus-host diseaseTissue repair
05

Safety considerations

Systemic immune suppressionOff-target inflammatory responsesPotential for cytokine release syndromeUnintended promotion of tumor growth
06

Biomarkers

Interleukin-10 (IL-10) levelsTransforming growth factor beta (TGF-beta) expressionIndoleamine 2,3-dioxygenase (IDO) activityProstaglandin E2 (PGE2) concentration

Beyond the preview

Go deeper on Paracrine Immunomodulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine Immunomodulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call